Tag: Biologics

The worldwide market for long-acting drug delivery technologies and services is experiencing notable growth. Marked by a substantial surge in demand and widespread adoption, this phase underscores the increasing acknowledgment and embrace of long-acting drug delivery solutions.  The global long-acting […]

The Biologics Contract Development and Manufacturing Organization (CDMO) sector is currently experiencing growth in its life cycle. This growth is marked by a rising acceptance of biologics, an increasing need for outsourced manufacturing services, and a growing investment in expanding […]